ArticleBioengineering (Basel, Switzerland)2021

Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer.

Vrinda Gote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.